ganitumab human monoclonal antibody type insulinlike growth factor receptor designed treatment ganitumab developed amgen phase iii clinical trial metastatic pancreatic cancer abandoned august monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikiganitumab